2020 Year in Review: Mechanical Ventilation During the First Year of the COVID-19 Pandemic

References

1. 1.↵
   1. Petty TL

   . Editorial: the adult respiratory distress syndrome (confessions of a “lumper”). Am Rev Respir Dis 1975;111(6):713-715.

   OpenUrlPubMedWeb of Science
2. 2.↵
   1. Rubenfeld GD

   . Is SARS just ARDS? JAMA 2003;290(3):397-399.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Bakewell S

   . How to live: or a life of Montaigne. New York: Other Press; 2010:128.
4. 4.↵
   1. Tobin MJ

   . The criteria used to justify endotracheal intubation of patients with COVID-19 are worrisome. Can J Anaesth 2021;68(2):258-259.

   OpenUrl
5. 5.↵
   1. Tobin MJ,
   2. Jubran A,
   3. Laghi F

   . Hypoxaemia does not necessitate tracheal intubation in COVID-19 patients. Br J Anaesth 2021;126(2):e75-e76.

   OpenUrl
6. 6.↵
   1. Tobin MJ

   . Does making a diagnosis of ARDS in patients with coronavirus disease 2019 matter? Chest 2020;158(6):2275-2277.

   OpenUrl
7. 7.↵
   1. Gattinoni L,
   2. Chiumello D,
   3. Caironi P,
   4. Busana M,
   5. Romitti F,
   6. Brazzi L,
   7. et al

   . COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020;46(6):1099-1102.

   OpenUrlPubMed
8. 8.↵
   1. Gattinoni L,
   2. Chiumello D,
   3. Rossi S

   . COVID-19 pneumonia: ARDS or not? Crit Care 2020;24(1):154.

   OpenUrlPubMed
9. 9.↵
   1. Honore PM,
   2. Barreto Gutierrez L,
   3. Kugener L,
   4. Redant S,
   5. Attou R,
   6. Gallerani A,
   7. et al

   . Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure. Crit Care 2020;24(1):482.

   OpenUrl
10. 10.
    1. Remy KE,
    2. Lin JC,
    3. Verhoef PA

    . High-flow nasal cannula may be no safer than non-invasive positive pressure ventilation for COVID-19 patients. Crit Care 2020;24(1):169.

    OpenUrl
11. 11.↵
    1. Cerceo E,
    2. Fraimow H

    . Lessons learned from the front line: outcomes of noninvasive ventilation for coronavirus disease 2019 pneumonia in China. Crit Care Med 2020;48(9):1400-1402.

    OpenUrl
12. 12.↵
    1. Macintyre CR,
    2. Seale H,
    3. Yang P,
    4. Zhang Y,
    5. Shi W,
    6. Almatroudi A,
    7. et al

    . Quantifying the risk of respiratory infection in healthcare workers performing high-risk procedures. Epidemiol Infect 2014;142(9):1802-1808.

    OpenUrlCrossRef
13. 13.↵
    1. Wu Z,
    2. McGoogan JM

    . Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239-1242.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Niederman MS,
    2. Richeldi L,
    3. Chotirmall SH,
    4. Bai C

    . Rising to the challenge of COVID-19: advice for pulmonary and critical care and an agenda for research. Am J Respir Crit Care Med 2020;201(9):1019-1022.

    OpenUrl
15. 15.↵
    1. Marini JJ,
    2. Gattinoni L

    . Management of COVID-19 respiratory distress. JAMA 2020;323(22):2329-2330.

    OpenUrlPubMed
16. 16.↵
    1. Gattinoni L,
    2. Marini JJ,
    3. Busana M,
    4. Chiumello D,
    5. Camporota L

    . Spontaneous breathing, transpulmonary pressure and mathematical trickery. Ann Intensive Care 2020;10(1):88.

    OpenUrl
17. 17.↵
    1. Li YC,
    2. Bai WZ,
    3. Hashikawa T

    . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020;92(6):552-555.

    OpenUrlPubMed
18. 18.↵
    1. Meng L,
    2. Qiu H,
    3. Wan L,
    4. Ai Y,
    5. Xue Z,
    6. Guo Q,
    7. et al

    . Intubation and ventilation amid the COVID-19 outbreak: Wuhan's experience. Anesthesiology 2020;132(6):1317-1332.

    OpenUrlPubMed
19. 19.↵
    1. Filipovic N,
    2. Saveljic I,
    3. Hamada K,
    4. Tsuda A

    . Abrupt deterioration of COVID-19 patients and spreading of SARS COV-2 virions in the lungs. Ann Biomed Eng 2020;48(12):2705-2706.

    OpenUrl
20. 20.↵
    1. Rello J,
    2. Storti E,
    3. Belliato M,
    4. Serrano R

    . Clinical phenotypes of SARS-CoV-2: implications for clinicians and researchers. Eur Respir J 2020;55(5):2001028.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Savel RH,
    2. Shiloh AL,
    3. Saunders PC,
    4. Kupfer Y

    . Mechanical ventilation during the coronavirus disease 2019 pandemic: combating the tsunami of misinformation from mainstream and social media. Crit Care Med 2020;48(9):1398-1400.

    OpenUrl
22. 22.↵
    1. Bahl A,
    2. Van Baalen MN,
    3. Ortiz L,
    4. Chen NW,
    5. Todd C,
    6. Milad M,
    7. et al

    . Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort. Intern Emerg Med 2020;15(8):1485-1499.

    OpenUrlCrossRef
23. 23.
    1. Zhou F,
    2. Yu T,
    3. Du R,
    4. Fan G,
    5. Liu Y,
    6. Liu Z,
    7. et al

    . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-1062.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Hua J,
    2. Qian C,
    3. Luo Z,
    4. Li Q,
    5. Wang F

    . Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in Wuhan. Crit Care 2020;24(1):348.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Chen T,
    2. Wu D,
    3. Chen H,
    4. Yan W,
    5. Yang D,
    6. Chen G,
    7. et al

    . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020;368:m1091.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Swenson KE,
    2. Ruoss SJ,
    3. Swenson ER

    . The pathophysiology and dangers of silent hypoxemia in COVID-19 lung injury. Ann Am Thorac Soc 2021 [Epub ahead of print].
27. 27.↵
    1. Raboud J,
    2. Shigayeva A,
    3. McGeer A,
    4. Bontovics E,
    5. Chapman M,
    6. Gravel D,
    7. et al

    . Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto, Canada. PLoS One 2010;5(5):e10717.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Bryson B

    . A short history of nearly everything. New York: Broadway Books; 2003:363.
29. 29.↵
    1. Li X,
    2. Ma X

    . Acute respiratory failure in COVID-19: is it “typical” ARDS? Crit Care 2020;24(1):198.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. Luks AM,
    2. Freer L,
    3. Grissom CK,
    4. McIntosh SE,
    5. Schoene RB,
    6. Swenson ER,
    7. et al

    . COVID-19 lung injury is not high altitude pulmonary edema. High Alt Med Biol 2020;21(2):192-193.

    OpenUrl
31. 31.↵
    1. Ashbaugh DG,
    2. Bigelow DB,
    3. Petty TL,
    4. Levine BE

    . Acute respiratory distress in adults. Lancet 1967;290(7511):319-323.

    OpenUrlCrossRef
32. 32.↵
    1. Barry J

    . The great influenza: the epic story of the deadliest plague in history. New York: Viking; 2004:250-252.
33. 33.↵
    1. Huang C,
    2. Wang Y,
    3. Li X,
    4. Ren L,
    5. Zhao J,
    6. Hu Y,
    7. et al

    . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Yang X,
    2. Yu Y,
    3. Xu J,
    4. Shu H,
    5. Xia J,
    6. Liu H,
    7. et al

    . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8(5):475-481.

    OpenUrlPubMed
35. 35.↵
    1. Rubenfeld GD,
    2. Caldwell E,
    3. Granton J,
    4. Hudson LD,
    5. Matthay MA

    . Interobserver variability in applying a radiographic definition for ARDS. Chest 1999;116(5):1347-1353.

    OpenUrlCrossRefPubMedWeb of Science
36. 36.↵
    1. Tsolaki V,
    2. Siempos I,
    3. Magira E,
    4. Kokkoris S,
    5. Zakynthinos GE,
    6. Zakynthinos S

    . PEEP levels in COVID-19 pneumonia. Crit Care 2020;24(1):303.

    OpenUrl
37. 37.↵
    1. Ferguson ND,
    2. Frutos-Vivar F,
    3. Esteban A,
    4. Fernandez-Segoviano P,
    5. Aramburu JA,
    6. Najera L,
    7. et al

    . Acute respiratory distress syndrome: underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med 2005;33(10):2228-2234.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Ranieri VM,
    2. Rubenfeld GD,
    3. Thompson BT,
    4. Ferguson ND,
    5. Caldwell E,
    6. et al

    ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526-2533.

    OpenUrlCrossRefPubMedWeb of Science
39. 39.↵
    1. Hudson LD,
    2. Milberg JA,
    3. Anardi D,
    4. Maunder RJ

    . Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;151(2 Pt 1):293-301.

    OpenUrlCrossRefPubMedWeb of Science
40. 40.↵
    1. Brower RG,
    2. Lanken PN,
    3. MacIntyre N,
    4. Matthay MA,
    5. Morris A,
    6. Ancukiewicz M,
    7. et al

    . Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;351(4):327-336.

    OpenUrlCrossRefPubMedWeb of Science
41. 41.
    1. Brower RG,
    2. Matthay MA,
    3. Morris A,
    4. Schoenfeld D,
    5. Thompson BT,
    6. et al

    Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301-1308.

    OpenUrlCrossRefPubMedWeb of Science
42. 42.
    1. Cavalcanti AB,
    2. Suzumura EA,
    3. Laranjeira LN,
    4. Paisani DM,
    5. Damiani LP,
    6. et al

    Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial Investigators, Cavalcanti AB, Suzumura EA, Laranjeira LN, Paisani DM, Damiani LP, et al. Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 2017;318(14):1335-1345.

    OpenUrlCrossRefPubMed
43. 43.↵
    1. Meade MO,
    2. Cook DJ,
    3. Guyatt GH,
    4. Slutsky AS,
    5. Arabi YM,
    6. Cooper DJ,
    7. et al

    . Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008;299(6):637-645.

    OpenUrlCrossRefPubMedWeb of Science
44. 44.↵
    1. Mercat A,
    2. Richard JC,
    3. Vielle B,
    4. Jaber S,
    5. Osman D,
    6. Diehl JL,
    7. et al

    . Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008;299(6):646-655.

    OpenUrlCrossRefPubMedWeb of Science
45. 45.↵
    1. Bos LDJ,
    2. Sinha P,
    3. Dickson RP

    . Response to COVID-19 phenotyping correspondence. Eur Respir J 2020;56(2):2002756.

    OpenUrlAbstract/FREE Full Text
46. 46.↵
    1. Bos LDJ,
    2. Sinha P,
    3. Dickson RP

    . The perils of premature phenotyping in COVID-19: a call for caution. Eur Respir J 2020;56(1):2001768.

    OpenUrlAbstract/FREE Full Text
47. 47.
    1. Gattinoni L,
    2. Camporota L,
    3. Marini JJ

    . COVID-19 phenotypes: leading or misleading? Eur Respir J 2020;56(2):2002195.

    OpenUrlAbstract/FREE Full Text
48. 48.
    1. Rajendram R

    . Building the house of CARDS by phenotyping on the fly. Eur Respir J 2020;56(2):2002429.

    OpenUrlAbstract/FREE Full Text
49. 49.
    1. Cherian R,
    2. Chandra B,
    3. Tung ML,
    4. Vuylsteke A

    . COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness. Eur Respir J 2020;56(2):2002135.

    OpenUrlAbstract/FREE Full Text
50. 50.↵
    1. Jain A,
    2. Doyle DJ

    . Stages or phenotypes? A critical look at COVID-19 pathophysiology. Intensive Care Med 2020;46(7):1494-1495.

    OpenUrl
51. 51.↵
    1. Henderson LA,
    2. Canna SW,
    3. Schulert GS,
    4. Volpi S,
    5. Lee PY,
    6. Kernan KF,
    7. et al

    . On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol 2020;72(7):1059-1063.

    OpenUrl
52. 52.↵
    1. Alharthy A,
    2. Faqihi F,
    3. Memish ZA,
    4. Karakitsos D

    . Lung injury in COVID-19: an emerging hypothesis. ACS Chem Neurosci 2020;11(15):2156-2158.

    OpenUrlCrossRefPubMed
53. 53.↵
    1. Kallet RH,
    2. Matthay MA

    . Hyperoxic acute lung injury. Respir Care 2013;58(1):123-141.

    OpenUrlAbstract/FREE Full Text
54. 54.↵
    1. Ngiam N,
    2. Kavanagh BP

    . Ventilator-induced lung injury: the role of gene activation. Curr Opin Crit Care 2012;18(1):16-22.

    OpenUrlCrossRefPubMed
55. 55.↵
    1. Calfee CS,
    2. Delucchi K,
    3. Parsons PE,
    4. Thompson BT,
    5. Ware LB,
    6. Matthay MA

    . Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2014;2(8):611-620.

    OpenUrlCrossRefPubMed
56. 56.
    1. Famous KR,
    2. Delucchi K,
    3. Ware LB,
    4. Kangelaris KN,
    5. Liu KD,
    6. Thompson BT,
    7. et al

    . Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 2017;195(3):331-338.

    OpenUrlCrossRefPubMed
57. 57.↵
    1. Lin SZ,
    2. Zhou D,
    3. Zhou F

    . Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome. Genes Dis 2020;7:520-527.

    OpenUrl
58. 58.↵
    1. Gattinoni L,
    2. Coppola S,
    3. Cressoni M,
    4. Busana M,
    5. Rossi S,
    6. Chiumello D

    . COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med 2020;201(10):1299-1300.

    OpenUrlCrossRefPubMed
59. 59.↵
    1. Raurich JM,
    2. Vilar M,
    3. Colomar A,
    4. Ibanez J,
    5. Ayestaran I,
    6. Perez-Barcena J,
    7. et al

    . Prognostic value of the pulmonary dead-space fraction during the early and intermediate phases of acute respiratory distress syndrome. Respir Care 2010;55(3):282-287.

    OpenUrlAbstract/FREE Full Text
60. 60.
    1. Nunes S,
    2. Valta P,
    3. Takala J

    . Changes in respiratory mechanics and gas exchange during the acute respiratory distress syndrome. Acta Anaesthesiol Scand 2006;50(1):80-91.

    OpenUrlPubMed
61. 61.
    1. Ranieri VM,
    2. Suter PM,
    3. Tortorella C,
    4. De Tullio R,
    5. Dayer JM,
    6. Brienza A,
    7. et al

    . Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999;282(1):54-61.

    OpenUrlCrossRefPubMedWeb of Science
62. 62.
    1. Esteban A,
    2. Alía I,
    3. Gordo F,
    4. de Pablo R,
    5. Suarez J,
    6. González G,
    7. Blanco J

    . Prospective randomized trial comparing pressure-controlled ventilation and volume-controlled ventilation in ARDS. For the Spanish Lung Failure Collaborative Group. Chest 2000;117(6):1690-1696.

    OpenUrlCrossRefPubMedWeb of Science
63. 63.↵
    1. Bellani G,
    2. Laffey JG,
    3. Pham T,
    4. Fan E,
    5. Brochard L,
    6. Esteban A,
    7. et al

    . Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016;315(8):788-800.

    OpenUrlCrossRefPubMed
64. 64.
    1. Chiumello D,
    2. Cressoni M,
    3. Carlesso E,
    4. Caspani ML,
    5. Marino A,
    6. Gallazzi E,
    7. et al

    . Bedside selection of positive end-expiratory pressure in mild, moderate, and severe acute respiratory distress syndrome. Crit Care Med 2014;42(2):252-264.

    OpenUrlCrossRefPubMed
65. 65.
    1. Gernoth C,
    2. Wagner G,
    3. Pelosi P,
    4. Luecke T

    . Respiratory and haemodynamic changes during decremental open lung positive end-expiratory pressure titration in patients with acute respiratory distress syndrome. Crit Care 2009;13(2):R59.

    OpenUrlCrossRefPubMed
66. 66.
    1. Gattinoni L,
    2. Caironi P,
    3. Cressoni M,
    4. Chiumello D,
    5. Ranieri VM,
    6. Quintel M,
    7. et al

    . Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 2006;354(17):1775-1786.

    OpenUrlCrossRefPubMedWeb of Science
67. 67.↵
    1. Chiumello D,
    2. Busana M,
    3. Coppola S,
    4. Romitti F,
    5. Formenti P,
    6. Bonifazi M,
    7. et al

    . Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study. Intensive Care Med 2020;46(12):2187-2196.

    OpenUrlCrossRefPubMed
68. 68.↵
    1. Alhazzani W,
    2. Møller MH,
    3. Arabi YM,
    4. Loeb M,
    5. Gong MN,
    6. Fan E,
    7. et al

    . Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med 2020;48(6):e440-e469.

    OpenUrlCrossRefPubMed
69. 69.↵
    1. Bos LDJ

    . COVID-19-related acute respiratory distress syndrome: not so atypical. Am J Respir Crit Care Med 2020;202(4):622-624.

    OpenUrl
70. 70.↵
    1. Tobin MJ

    . Culmination of an era in research on the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1360-1361.

    OpenUrlCrossRefPubMedWeb of Science
71. 71.↵
    1. Kallet RH,
    2. Campbell AR,
    3. Dicker RA,
    4. Katz JA,
    5. Mackersie RC

    . Effects of tidal volume on work of breathing during lung-protective ventilation in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med 2006;34(1):8-14.

    OpenUrlPubMed
72. 72.↵
    1. Fan E,
    2. Beitler JR,
    3. Brochard L,
    4. Calfee CS,
    5. Ferguson ND,
    6. Slutsky AS,
    7. et al

    . COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med 2020;8(8):816-821.

    OpenUrl
73. 73.↵
    1. Rice TW,
    2. Janz DR

    . In defense of evidence-based medicine for the treatment of COVID-19 acute respiratory distress syndrome. Ann Am Thorac Soc 2020;17(7):787-789.

    OpenUrl
74. 74.↵
    1. Kollef MH,
    2. Levy NT,
    3. Ahrens TS,
    4. Schaiff R,
    5. Prentice D,
    6. Sherman G

    . The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998;114(2):541-548.

    OpenUrlCrossRefPubMedWeb of Science
75. 75.
    1. Jones C,
    2. Bäckman C,
    3. Capuzzo M,
    4. Flaatten H,
    5. Rylander C,
    6. Griffiths RD

    . Precipitants of post-traumatic stress disorder following intensive care: a hypothesis generating study of diversity in care. Intensive Care Med 2007;33(6):978-985.

    OpenUrlCrossRefPubMedWeb of Science
76. 76.↵
    1. Wade DM,
    2. Howell DC,
    3. Weinman JA,
    4. Hardy RJ,
    5. Mythen MG,
    6. Brewin CR,
    7. et al

    . Investigating risk factors for psychological morbidity three months after intensive care: a prospective cohort study. Crit Care 2012;16(5):R192.

    OpenUrlCrossRefPubMed
77. 77.↵
    1. Epstein SK

    . How often does patient-ventilator asynchrony occur and what are the consequences? Respir Care 2011;56(1):25-38.

    OpenUrlAbstract/FREE Full Text
78. 78.↵
    1. Martos-Benitez FD,
    2. Dominguez-Valdes Y,
    3. Burgos-Araguez D,
    4. Larrondo-Muguercia H,
    5. Orama-Requejo V,
    6. Lara-Ponce KX,
    7. et al

    . Outcomes of ventilatory asynchrony in patients with inspiratory effort. Rev Bras Ter Intensiva 2020;32(2):284-294.

    OpenUrl
79. 79.↵
    1. Tabone L,
    2. Martin S,
    3. Emeriaud G

    . Positive end-expiratory pressure in coronavirus disease 2019 acute respiratory distress syndrome: higher may be too high. Crit Care Med 2020;48(12):1925-1927.

    OpenUrl
80. 80.↵
    1. Grasso S,
    2. Mirabella L,
    3. Murgolo F,
    4. Di Mussi R,
    5. Pisani L,
    6. Dalfino L,
    7. et al

    . Effects of positive end-expiratory pressure in “high compliance” severe acute respiratory syndrome coronavirus 2 acute respiratory distress syndrome. Crit Care Med 2020;48(12):e1332-e1336.

    OpenUrlCrossRefPubMed
81. 81.↵
    1. Tsolaki V,
    2. Zakynthinos GE,
    3. Makris D

    . The ARDSnet protocol may be detrimental in COVID-19. Crit Care 2020;24(1):351.

    OpenUrl
82. 82.↵
    1. Chiumello D,
    2. Camporota L,
    3. Gattinoni L,
    4. Marini JJ

    . Complexity and unanswered questions in the pathophysiology of COVID-19 ARDS. Intensive Care Med 2021;47(4):495-496.

    OpenUrl
83. 83.↵
    1. Bos LDJ,
    2. Paulus F,
    3. Vlaar APJ,
    4. Beenen LFM,
    5. Schultz MJ

    . Subphenotyping acute respiratory distress syndrome in patients with COVID-19: consequences for ventilator management. Ann Am Thorac Soc 2020;17(9):1161-1163.

    OpenUrl
84. 84.↵
    1. Shi H,
    2. Han X,
    3. Jiang N,
    4. Cao Y,
    5. Alwalid O,
    6. Gu J,
    7. et al

    . Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020;20(4):425-434.

    OpenUrlPubMed
85. 85.↵
    1. Pan Y,
    2. Guan H,
    3. Zhou S,
    4. Wang Y,
    5. Li Q,
    6. Zhu T,
    7. et al

    . Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. Eur Radiol 2020;30(6):3306-3309.

    OpenUrlPubMed
86. 86.↵
    1. Copin MC,
    2. Parmentier E,
    3. Duburcq T,
    4. Poissy J,
    5. Mathieu D

    , Lille COVID-19 ICU and Anatomopathology Group. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intensive Care Med 2020;46(6):1124-1126.

    OpenUrlPubMed
87. 87.↵
    1. Mauad T,
    2. Duarte-Neto AN,
    3. da Silva LFF,
    4. de Oliveira EP,
    5. de Brito JM,
    6. do Nascimento ECT,
    7. et al

    . Tracking the time course of pathological patterns of lung injury in severe COVID-19. Respir Res 2021;22(1):32.

    OpenUrl
88. 88.↵
    1. Bösmüller H,
    2. Traxler S,
    3. Bitzer M,
    4. Haberle H,
    5. Raiser W,
    6. Nann D,
    7. et al

    . The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation. Virchows Arch 2020;477(3):349-357.

    OpenUrl
89. 89.↵
    1. Oz M,
    2. Lorke DE

    . Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury. Biomed Pharmacother 2021;136:111193.

    OpenUrl
90. 90.↵
    1. Wang D,
    2. Chai XQ,
    3. Magnussen CG,
    4. Zosky GR,
    5. Shu SH,
    6. Wei X,
    7. et al

    . Renin-angiotensin-system, a potential pharmacological candidate, in acute respiratory distress syndrome during mechanical ventilation. Pulm Pharmacol Ther 2019;58:101833.

    OpenUrl
91. 91.↵
    1. Gattinoni L,
    2. Marini JJ,
    3. Chiumello D,
    4. Busana M,
    5. Camporota L

    . COVID-19: scientific reasoning, pragmatism and emotional bias. Ann Intensive Care 2020;10(1):134.

    OpenUrl
92. 92.↵
    1. Gattinoni L,
    2. Marini JJ,
    3. Camporota L

    . The respiratory drive: an overlooked tile of COVID-19 pathophysiology. Am J Respir Crit Care Med 2020;202(8):1079-1080.

    OpenUrl
93. 93.↵
    1. Cruces P,
    2. Retamal J,
    3. Hurtado DE,
    4. Erranz B,
    5. Iturrieta P,
    6. González C,
    7. et al

    . A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection. Crit Care 2020;24(1):494.

    OpenUrl
94. 94.↵
    1. Dreyfuss D,
    2. Soler P,
    3. Basset G,
    4. Saumon G

    . High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988;137(5):1159-1164.

    OpenUrlCrossRefPubMedWeb of Science
95. 95.↵
    1. Mascheroni D,
    2. Kolobow T,
    3. Fumagalli R,
    4. Moretti MP,
    5. Chen V,
    6. Buckhold D

    . Acute respiratory failure following pharmacologically induced hyperventilation: an experimental animal study. Intensive Care Med 1988;15(1):8-14.

    OpenUrlCrossRefPubMedWeb of Science
96. 96.↵
    1. Yoshida T,
    2. Uchiyama A,
    3. Matsuura N,
    4. Mashimo T,
    5. Fujino Y

    . Spontaneous breathing during lung-protective ventilation in an experimental acute lung injury model: high transpulmonary pressure associated with strong spontaneous breathing effort may worsen lung injury. Crit Care Med 2012;40(5):1578-1585.

    OpenUrlCrossRefPubMed
97. 97.↵
    1. Adams AB,
    2. Graf J

    . Does mechanical ventilation “hit” the lungs? Crit Care Med 2008;36(8):2471-2473.

    OpenUrlPubMed
98. 98.↵
    1. Maniatis NA,
    2. Kotanidou A,
    3. Catravas JD,
    4. Orfanos SE

    . Endothelial pathomechanisms in acute lung injury. Vascul Pharmacol 2008;49:119-133.

    OpenUrlCrossRefPubMedWeb of Science
99. 99.↵
    1. Hubmayr RD,
    2. Kallet RH

    . Understanding pulmonary stress-strain relationships in severe ARDS and its implications for designing a safer approach to setting the ventilator. Respir Care 2018;63(2):219-226.

    OpenUrlAbstract/FREE Full Text
100. 100.↵
     1. Amato MB,
     2. Meade MO,
     3. Slutsky AS,
     4. Brochard L,
     5. Costa EL,
     6. Schoenfeld DA,
     7. et al

     . Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 2015;372(8):747-755.

     OpenUrlCrossRefPubMed
101. 101.↵
     1. Bertoni M,
     2. Telias I,
     3. Urner M,
     4. Long M,
     5. Del Sorbo L,
     6. Fan E,
     7. et al

     . A novel non-invasive method to detect excessively high respiratory effort and dynamic transpulmonary driving pressure during mechanical ventilation. Crit Care 2019;23(1):346.

     OpenUrl
102. 102.↵
     1. Kallet RH,
     2. Hemphill JC 3rd.,
     3. Dicker RA,
     4. Alonso JA,
     5. Campbell AR,
     6. Mackersie RC,
     7. et al

     . The spontaneous breathing pattern and work of breathing of patients with acute respiratory distress syndrome and acute lung injury. Respir Care 2007;52(8):989-995.

     OpenUrlAbstract/FREE Full Text
103. 103.↵
     1. Esnault P,
     2. Cardinale M,
     3. Hraiech S,
     4. Goutorbe P,
     5. Baumstrack K,
     6. Prud'homme E,
     7. et al

     . High respiratory drive and excessive respiratory efforts predict relapse of respiratory failure in critically ill patients with COVID-19. Am J Respir Crit Care Med 2020;202(8):1173-1178.

     OpenUrl
104. 104.↵
     1. Carteaux G,
     2. Millán-Guilarte T,
     3. De Prost N,
     4. Razazi K,
     5. Abid S,
     6. Thille AW,
     7. et al

     . Failure of noninvasive ventilation for de novo acute hypoxemic respiratory failure: role of tidal volume. Crit Care Med 2016;44(2):282-290.

     OpenUrlCrossRefPubMed
105. 105.↵
     1. Richardson S,
     2. Hirsch JS,
     3. Narasimhan M,
     4. Crawford JM,
     5. McGinn T,
     6. Davidson KW,
     7. et al

     . Presenting characteristics, comorbidities, and outcomes among 5,700 patients hospitalized with COVID-19 in the New York City area. JAMA 2020;323(20):2052-2059.

     OpenUrlCrossRefPubMed
106. 106.↵
     1. Barbeta E,
     2. Motos A,
     3. Torres A,
     4. Ceccato A,
     5. Ferrer M,
     6. Cilloniz C,
     7. et al

     . SARS-CoV-2-induced acute respiratory distress syndrome: pulmonary mechanics and gas-exchange abnormalities. Ann Am Thorac Soc 2020;17(9):1164-1168.

     OpenUrl
107. 107.↵
     1. Ferrando C,
     2. Suarez-Sipmann F,
     3. Mellado-Artigas R,
     4. Hernández M,
     5. Gea A,
     6. Arruti E,
     7. et al

     . Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med 2020;46(12):2200-2211.

     OpenUrl
108. 108.
     1. Argenziano MG,
     2. Bruce SL,
     3. Slater CL,
     4. Tiao JR,
     5. Baldwin MR,
     6. Barr RG,
     7. et al

     . Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ 2020;369:m1996.

     OpenUrlAbstract/FREE Full Text
109. 109.
     1. Yang SS,
     2. Lipes J,
     3. Dial S,
     4. Schwartz B,
     5. Laporta D,
     6. Wong E,
     7. et al

     . Outcomes and clinical practice in patients with COVID-19 admitted to the intensive care unit in Montreal, Canada: a descriptive analysis. CMAJ Open 2020;8(4):E788-E795.

     OpenUrlAbstract/FREE Full Text
110. 110.↵
     1. Schenck EJ,
     2. Hoffman K,
     3. Goyal P,
     4. Choi J,
     5. Torres L,
     6. Rajwani K,
     7. et al

     . Respiratory mechanics and gas exchange in COVID-19-associated respiratory failure. Ann Am Thorac Soc 2020;17(9):1158-1161.

     OpenUrlCrossRefPubMed
111. 111.
     1. Suleyman G,
     2. Fadel RA,
     3. Malette KM,
     4. Hammond C,
     5. Abdulla H,
     6. Entz A,
     7. et al

     . Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open 2020;3(6):e2012270.

     OpenUrlPubMed
112. 112.
     1. Salacup G,
     2. Lo KB,
     3. Gul F,
     4. Peterson E,
     5. De Joy R,
     6. Bhargav R,
     7. et al

     . Characteristics and clinical outcomes of COVID-19 patients in an underserved-inner city population: a single tertiary center cohort. J Med Virol 2021;93(1):416-423.

     OpenUrlCrossRef
113. 113.↵
     1. Mitra AR,
     2. Fergusson NA,
     3. Lloyd-Smith E,
     4. Wormsbecker A,
     5. Foster D,
     6. Karpov A,
     7. et al

     . Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series. CMAJ 2020;192(26):E694-E701.

     OpenUrlAbstract/FREE Full Text
114. 114.
     1. Ferguson J,
     2. Rosser JI,
     3. Quintero O,
     4. Scott J,
     5. Subramanian A,
     6. Gumma M,
     7. et al

     . Characteristics and outcomes of coronavirus disease patients under non-surge conditions, Northern California, USA, March-April 2020. Emerg Infect Dis 2020;26(8):1679-1685.

     OpenUrlPubMed
115. 115.↵
     1. Botta M,
     2. Tsonas AM,
     3. Pillay J,
     4. Boers LS,
     5. Algera AG,
     6. Bos LDJ,
     7. et al

     . Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study. Lancet Respir Med 2021;9(2):139-148.

     OpenUrl
116. 116.↵
     COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4,244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 2021;47(1):60-73.

     OpenUrlPubMed
117. 117.↵
     1. Regina J,
     2. Papadimitriou-Olivgeris M,
     3. Burger R,
     4. Le Pogam MA,
     5. Niemi T,
     6. Filippidis P,
     7. et al

     . Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: an observational retrospective study. PLoS One 2020;15(11):e0240781.

     OpenUrl
118. 118.
     1. Israelsen SB,
     2. Kristiansen KT,
     3. Hindsberger B,
     4. Ulrik CS,
     5. Andersen O,
     6. Jensen M,
     7. et al

     . Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020. Dan Med J 2020;67(6):A05200313.

     OpenUrl
119. 119.
     1. Khamis F,
     2. Al-Zakwani I,
     3. Al Naamani H,
     4. Al Lawati S,
     5. Pandak N,
     6. Ba Omar M,
     7. et al

     . Clinical characteristics and outcomes of the first 63 adult patients hospitalized with COVID-19: an experience from Oman. J Infect Public Health 2020;13:906-913.

     OpenUrlCrossRefPubMed
120. 120.↵
     1. Hernandez-Romieu AC,
     2. Adelman MW,
     3. Hockstein MA,
     4. Robichaux CJ,
     5. Edwards JA,
     6. Fazio JC,
     7. et al

     . Timing of intubation and mortality among critically ill coronavirus disease 2019 patients: a single-center cohort study. Crit Care Med 2020;48(11):e1045-e1053.

     OpenUrlCrossRefPubMed
121. 121.↵
     1. Wang T,
     2. Tang C,
     3. Chen R,
     4. Ruan H,
     5. Liang W,
     6. Guan W,
     7. et al

     . Clinical features of coronavirus disease 2019 patients with mechanical ventilation: a nationwide study in China. Crit Care Med 2020;48(9):e809-e812.

     OpenUrlPubMed
122. 122.↵
     1. Grasselli G,
     2. Greco M,
     3. Zanella A,
     4. Albano G,
     5. Antonelli M,
     6. Bellani G,
     7. et al

     . Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med 2020;180(10):1345-1355.

     OpenUrl
123. 123.
     1. Haase N,
     2. Plovsing R,
     3. Christensen S,
     4. Poulsen LM,
     5. Brøchner AC,
     6. Rasmussen BS,
     7. et al

     . Characteristics, interventions, and longer term outcomes of COVID-19 ICU patients in Denmark: a nationwide, observational study. Acta Anaesthesiol Scand 2021;65(1):68-75.

     OpenUrlPubMed
124. 124.
     1. Almazeedi S,
     2. Al-Youha S,
     3. Jamal MH,
     4. Al-Haddad M,
     5. Al-Muhaini A,
     6. Al-Ghimlas F,
     7. Al-Sabah S

     . Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine 2020;24:100448.

     OpenUrl
125. 125.↵
     1. Karagiannidis C,
     2. Mostert C,
     3. Hentschker C,
     4. Voshaar T,
     5. Malzahn J,
     6. Schillinger G

     . Case characteristics, resource use, and outcomes of 10,021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med 2020;8(9):853-862.

     OpenUrl
126. 126.↵
     1. Giacomelli A,
     2. Ridolfo AL,
     3. Milazzo L,
     4. Oreni L,
     5. Bernacchia D,
     6. Siano M,
     7. et al

     . 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study. Pharmacol Res 2020;158:104931.

     OpenUrlPubMed
127. 127.↵
     1. Cummings MJ,
     2. Baldwin MR,
     3. Abrams D,
     4. Jacobson SD,
     5. Meyer BJ,
     6. Balough EM,
     7. et al

     . Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet 2020;395(10239):1763-1770.

     OpenUrlCrossRefPubMed
128. 128.↵
     1. Cantini F,
     2. Goletti D,
     3. Petrone L,
     4. Najafi Fard S,
     5. Niccoli L,
     6. Foti R

     . Immune therapy, or antiviral therapy, or both for COVID-19: a systematic review. Drugs 2020;80(18):1929-1946.

     OpenUrl
129. 129.↵
     1. Lim ZJ,
     2. Subramaniam A,
     3. Ponnapa Reddy M,
     4. Blecher G,
     5. Kadam U,
     6. Afroz A,
     7. et al

     . Case fatality rates for patients with COVID-19 requiring invasive mechanical ventilation: a meta-analysis. Am J Respir Crit Care Med 2021;203(1):54-66.

     OpenUrlCrossRef
130. 130.↵
     1. Domecq JP,
     2. Lal A,
     3. Sheldrick CR,
     4. Kumar VK,
     5. Boman K,
     6. Bolesta S,
     7. et al

     . Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and respiratory illness universal study registry. Crit Care Med 2021;49(3):437-448.

     OpenUrl
131. 131.↵
     1. Malek M,
     2. Hassanshahi J,
     3. Fartootzadeh R,
     4. Azizi F,
     5. Shahidani S

     . Nephrogenic acute respiratory distress syndrome: a narrative review on pathophysiology and treatment. Chin J Traumatol 2018;21(1):4-10.

     OpenUrl
132. 132.↵
     1. Fowler RA,
     2. Lapinsky SE,
     3. Hallett D,
     4. Detsky AS,
     5. Sibbald WJ,
     6. Slutsky AS,
     7. et al

     . Critically ill patients with severe acute respiratory syndrome. JAMA 2003;290(3):367-373.

     OpenUrlCrossRefPubMedWeb of Science
133. 133.↵
     1. Gomersall CD,
     2. Joynt GM,
     3. Lam P,
     4. Li T,
     5. Yap F,
     6. Lam D,
     7. et al

     . Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med 2004;30(3):381-387.

     OpenUrlCrossRefPubMedWeb of Science
134. 134.↵
     1. Al-Dorzi HM,
     2. Aldawood AS,
     3. Khan R,
     4. Baharoon S,
     5. Alchin JD,
     6. Matroud AA,
     7. et al

     . The critical care response to a hospital outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) infection: an observational study. Ann Intensive Care 2016;6(1):101.

     OpenUrl
135. 135.
     1. Saad M,
     2. Omrani AS,
     3. Baig K,
     4. Bahloul A,
     5. Elzein F,
     6. Matin MA,
     7. et al

     . Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis 2014;29:301-306.

     OpenUrlCrossRefPubMed
136. 136.↵
     1. Morra ME,
     2. Van Thanh L,
     3. Kamel MG,
     4. Ghazy AA,
     5. Altibi AMA,
     6. Dat LM,
     7. et al

     . Clinical outcomes of current medical approaches for Middle East respiratory syndrome: a systematic review and meta-analysis. Rev Med Virol 2018;28(3):e1977.

     OpenUrlPubMed
137. 137.↵
     1. Fominskiy EV,
     2. Scandroglio AM,
     3. Monti G,
     4. Calabrò MG,
     5. Landoni G,
     6. Dell'Acqua A,
     7. et al

     . Prevalence, characteristics, risk factors, and outcomes of invasively ventilated COVID-19 patients with acute kidney injury and renal replacement therapy. Blood Purif 2021;50(1):102-109.

     OpenUrl
138. 138.↵
     1. Villar J,
     2. Blanco J,
     3. Añón JM,
     4. Santos-Bouza A,
     5. Blanch L,
     6. Ambrós A,
     7. et al

     . The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation. Intensive Care Med 2011;37(12):1932-1941.

     OpenUrlCrossRefPubMedWeb of Science
139. 139.↵
     1. Kallet RH,
     2. Zhuo H,
     3. Yip V,
     4. Gomez A,
     5. Lipnick MS

     . Spontaneous breathing trials and conservative sedation practices reduce mechanical ventilation duration in subjects with ARDS. Respir Care 2018;63(1):1-10.

     OpenUrlAbstract/FREE Full Text
140. 140.↵
     1. Grasselli G,
     2. Zangrillo A,
     3. Zanella A,
     4. Antonelli M,
     5. Cabrini L,
     6. Castelli A,
     7. et al

     . Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA 2020;323(16):1574-1581.

     OpenUrlCrossRefPubMed
141. 141.↵
     1. Ziehr DR,
     2. Alladina J,
     3. Petri CR,
     4. Maley JH,
     5. Moskowitz A,
     6. Medoff BD,
     7. et al

     . Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care Med 2020;201(12):1560-1564.

     OpenUrlCrossRefPubMed
142. 142.↵
     1. Zangrillo A,
     2. Beretta L,
     3. Scandroglio AM,
     4. Monti G,
     5. Fominskiy E,
     6. Colombo S,
     7. et al

     . Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc 2020;22(3):200-211.

     OpenUrl
143. 143.↵
     1. Bhatraju PK,
     2. Ghassemieh BJ,
     3. Nichols M,
     4. Kim R,
     5. Jerome KR,
     6. Nalla AK,
     7. et al

     . Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med 2020;382(21):2012-2022.

     OpenUrlCrossRefPubMed
144. 144.↵
     1. Rojatta M,
     2. Regli IB,
     3. Zanforlin A,
     4. Ferretti E,
     5. Falk M,
     6. Strapazzon G,
     7. et al

     . Lung ultrasound and respiratory pathophysiology in mechanically ventilated COVID-19 patients: an observational trial. SN Compr Clin Med 2020 [Epub ahead of print] doi: doi:10.1007/s42399-020-00536-1.

     OpenUrlCrossRef
145. 145.↵
     1. Sjoding MW,
     2. Admon AJ,
     3. Saha AK,
     4. Kay SG,
     5. Brown CA,
     6. Co I,
     7. et al

     . Comparing clinical features and outcomes in mechanically ventilated patients with COVID-19 and the acute respiratory distress syndrome. Ann Am Thorac Soc 2021 [Epub ahead of print] doi: doi:10.1513/Annals ATS.202008-1076OC.

     OpenUrlCrossRef
146. 146.↵
     1. Haudebourg AF,
     2. Perier F,
     3. Tuffet S,
     4. de Prost N,
     5. Razazi K,
     6. Mekontso Dessap A,
     7. Carteaux G

     . Respiratory mechanics of COVID-19- versus non-COVID-19-associated acute respiratory distress syndrome. Am J Respir Crit Care Med 2020;202(2):287-290.

     OpenUrlCrossRefPubMed
147. 147.↵
     1. Lenka J,
     2. Chhabria MS,
     3. Sharma N,
     4. Tan BE,
     5. Boppana LKT,
     6. Venugopal S,
     7. et al

     . Clinical characteristics and outcomes of critically ill patients with COVID-19 in a tertiary community hospital in upstate New York. J Community Hosp Intern Med Perspect 2020;10(6):491-500.

     OpenUrl
148. 148.↵
     1. Brault C,
     2. Zerbib Y,
     3. Kontar L,
     4. Fouquet U,
     5. Carpentier M,
     6. Metzelard M,
     7. et al

     . COVID-19- versus non-COVID-19-related acute respiratory distress syndrome: differences and similarities. Am J Respir Crit Care Med 2020;202(9):1301-1304.

     OpenUrlCrossRefPubMed
149. 149.↵
     1. Diehl JL,
     2. Peron N,
     3. Chocron R,
     4. Debuc B,
     5. Guerot E,
     6. Hauw-Berlemont C,
     7. et al

     . Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study. Ann Intensive Care 2020;10(1):95.

     OpenUrlCrossRef
150. 150.↵
     1. Vandenbunder B,
     2. Ehrmann S,
     3. Piagnerelli M,
     4. Sauneuf B,
     5. Serck N,
     6. Soumagne T,
     7. et al

     . Static compliance of the respiratory system in COVID-19 related ARDS: an international multicenter study. Crit Care 2021;25(1):52.

     OpenUrl
151. 151.↵
     1. Liu X,
     2. Liu X,
     3. Xu Y,
     4. Xu Z,
     5. Huang Y,
     6. Chen S,
     7. et al

     . Ventilatory ratio in hypercapnic mechanically ventilated patients with COVID-19-associated acute respiratory distress syndrome. Am J Respir Crit Care Med 2020;201(10):1297-1299.

     OpenUrlCrossRef
152. 152.↵
     1. Kassis ES,
     2. Maley JH,
     3. Hoenig B,
     4. Loo Y,
     5. Hayes MM,
     6. Moskowitz A,
     7. Talmor D

     . Transpulmonary pressure measurements and lung mechanics in patients with early ARDS and SARS-Co-2. J Crit Care 2021;63:106-112.

     OpenUrl
153. 153.↵
     1. Beloncle FM,
     2. Pavlovsky B,
     3. Desprez C,
     4. Fage N,
     5. Olivier PY,
     6. Asfar P,
     7. et al

     . Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome. Ann Intensive Care 2020;10(1):55.

     OpenUrl
154. 154.↵
     1. Kallet RH

     . Should PEEP titration be based on chest mechanics in patients with ARDS? Respir Care 2016;61(6):876-890.

     OpenUrlAbstract/FREE Full Text
155. 155.↵
     1. Arentz M,
     2. Yim E,
     3. Klaff L,
     4. Lokhandwala S,
     5. Riedo FX,
     6. Chong M,
     7. et al

     . Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA 2020;323(16):1612-1614.

     OpenUrlCrossRefPubMed
156. 156.↵
     Network C-IGobotR, the C-ICUI. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 2021;47(1):60-73.

     OpenUrlPubMed
157. 157.↵
     1. Auld SC,
     2. Caridi-Scheible M,
     3. Blum JM,
     4. Robichaux C,
     5. Kraft C,
     6. Jacob JT,
     7. et al

     . ICU and ventilator mortality among critically ill adults with coronavirus disease 2019. Crit Care Med 2020;48(9):e799-e804.

     OpenUrlCrossRefPubMed
158. 158.↵
     1. Amato MB,
     2. Barbas CS,
     3. Medeiros DM,
     4. Magaldi RB,
     5. Schettino GP,
     6. Lorenzi-Filho G,
     7. et al

     . Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998;338(6):347-354.

     OpenUrlCrossRefPubMedWeb of Science
159. 159.
     1. Talmor D,
     2. Sarge T,
     3. Malhotra A,
     4. O'Donnell CR,
     5. Ritz R,
     6. Lisbon A,
     7. et al

     . Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 2008;359(20):2095-2104.

     OpenUrlCrossRefPubMedWeb of Science
160. 160.↵
     1. Kallet RH,
     2. Zhuo H,
     3. Ho K,
     4. Lipnick MS,
     5. Gomez A,
     6. Matthay MA

     . Lung injury etiology and other factors influencing the relationship between dead-space fraction and mortality in ARDS. Respir Care 2017;62(10):1241-1248.

     OpenUrlAbstract/FREE Full Text
161. 161.↵
     1. Kallet RH,
     2. Katz JA

     . Respiratory system mechanics in acute respiratory distress syndrome. Respir Care Clin N Am 2003;9(3):297-319.

     OpenUrlCrossRefPubMed
162. 162.↵
     1. Kallet RH,
     2. Lipnick MS,
     3. Burns GD

     . The nature of recruitment and de-recruitment and its implications for management of ARDS. Respir Care 2021;66(3):510-530.

     OpenUrlAbstract/FREE Full Text
163. 163.↵
     1. Pan C,
     2. Chen L,
     3. Lu C,
     4. Zhang W,
     5. Xia JA,
     6. Sklar MC,
     7. et al

     . Lung recruitability in COVID-19-associated acute respiratory distress syndrome: a single-center observational study. Am J Respir Crit Care Med 2020;201(10):1294-1297.

     OpenUrlPubMed
164. 164.↵
     1. Mauri T,
     2. Spinelli E,
     3. Scotti E,
     4. Colussi G,
     5. Basile MC,
     6. Crotti S,
     7. et al

     . Potential for lung recruitment and ventilation-perfusion mismatch in patients with the acute respiratory distress syndrome from coronavirus disease 2019. Crit Care Med 2020;48(8):1129-1134.

     OpenUrlPubMed
165. 165.↵
     1. Chen L,
     2. Del Sorbo L,
     3. Grieco DL,
     4. Junhasavasdikul D,
     5. Rittayamai N,
     6. Soliman I,
     7. et al

     . Potential for lung recruitment estimated by the recruitment-to-inflation ratio in acute respiratory distress syndrome: a clinical trial. Am J Respir Crit Care Med 2020;201(2):178-187.

     OpenUrlCrossRefPubMed
166. 166.↵
     1. Antonelli M,
     2. Conti G,
     3. Moro ML,
     4. Esquinas A,
     5. Gonzalez-Diaz G,
     6. Confalonieri M,
     7. et al

     . Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med 2001;27(11):1718-1728.

     OpenUrlCrossRefPubMedWeb of Science
167. 167.↵
     1. Bellani G,
     2. Laffey JG,
     3. Pham T,
     4. Madotto F,
     5. Fan E,
     6. Brochard L,
     7. et al

     . Noninvasive ventilation of patients with acute respiratory distress syndrome: insights from the LUNG SAFE study. Am J Respir Crit Care Med 2017;195(1):67-77.

     OpenUrlCrossRefPubMed
168. 168.↵
     1. Antonelli M,
     2. Conti G,
     3. Esquinas A,
     4. Montini L,
     5. Maggiore SM,
     6. Bello G,
     7. et al

     . A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med 2007;35(1):18-25.

     OpenUrlCrossRefPubMedWeb of Science
169. 169.↵
     1. Chawla R,
     2. Mansuriya J,
     3. Modi N,
     4. Pandey A,
     5. Juneja D,
     6. Chawla A,
     7. et al

     . Acute respiratory distress syndrome: predictors of noninvasive ventilation failure and intensive care unit mortality in clinical practice. J Crit Care 2016;31(1):26-30.

     OpenUrl
170. 170.↵
     1. Thille AW,
     2. Contou D,
     3. Fragnoli C,
     4. Córdoba-Izquierdo A,
     5. Boissier F,
     6. Brun-Buisson C

     . Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors. Crit Care 2013;17(6):R269.

     OpenUrlCrossRefPubMed
171. 171.
     1. Yoshida Y,
     2. Takeda S,
     3. Akada S,
     4. Hongo T,
     5. Tanaka K,
     6. Sakamoto A

     . Factors predicting successful noninvasive ventilation in acute lung injury. J Anesth 2008;22(3):201-206.

     OpenUrlCrossRefPubMedWeb of Science
172. 172.↵
     1. Sehgal IS,
     2. Chaudhuri S,
     3. Dhooria S,
     4. Agarwal R,
     5. Chaudhry D

     . A study on the role of noninvasive ventilation in mild-to-moderate acute respiratory distress syndrome. Indian J Crit Care Med 2015;19(10):593-599.

     OpenUrl
173. 173.↵
     1. Suttapanit K,
     2. Boriboon J,
     3. Sanguanwit P

     . Risk factors for non-invasive ventilation failure in influenza infection with acute respiratory failure in emergency department. Am J Emerg Med 2020;38(9):1901-1907.

     OpenUrl
174. 174.↵
     1. Cheung TM,
     2. Yam LY,
     3. So LK,
     4. Lau AC,
     5. Poon E,
     6. Kong BM,
     7. et al

     . Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome. Chest 2004;126(3):845-850.

     OpenUrlCrossRefPubMedWeb of Science
175. 175.
     1. Han F,
     2. Jiang YY,
     3. Zheng JH,
     4. Gao ZC,
     5. He QY

     . Noninvasive positive pressure ventilation treatment for acute respiratory failure in SARS. Sleep Breath 2004;8(2):97-106.

     OpenUrlCrossRefPubMed
176. 176.↵
     1. Yam LY,
     2. Chen RC,
     3. Zhong NS

     . SARS: ventilatory and intensive care. Respirology 2003;8 Suppl(Suppl 1):S31-S35.

     OpenUrlCrossRefPubMedWeb of Science
177. 177.↵
     1. Masclans JR,
     2. Perez M,
     3. Almirall J,
     4. Lorente L,
     5. Marqués A,
     6. Socias L,
     7. et al

     . Early non-invasive ventilation treatment for severe influenza pneumonia. Clin Microbiol Infect 2013;19(3):249-256.

     OpenUrlCrossRefPubMed
178. 178.
     1. Rello J,
     2. Rodríguez A,
     3. Ibañez P,
     4. Socias L,
     5. Cebrian J,
     6. Marques A,
     7. et al

     . Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 2009;13(5):R148.

     OpenUrlCrossRefPubMed
179. 179.
     1. Kumar A,
     2. Zarychanski R,
     3. Pinto R,
     4. Cook DJ,
     5. Marshall J,
     6. Lacroix J,
     7. et al

     . Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302(17):1872-1879.

     OpenUrlCrossRefPubMedWeb of Science
180. 180.↵
     1. Domínguez-Cherit G,
     2. Lapinsky SE,
     3. Macias AE,
     4. Pinto R,
     5. Espinosa-Perez L,
     6. de la Torre A,
     7. et al

     . Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009;302(17):1880-1887.

     OpenUrlCrossRefPubMedWeb of Science
181. 181.↵
     1. Alraddadi BQ,
     2. Al-Hameed FM,
     3. Mandourah Y,
     4. Almekhlafi GA,
     5. Jose J,
     6. Al-Omari A,
     7. et al

     . Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome. Influenza Other Respir Viruses 2019;13:382-390.

     OpenUrlCrossRefPubMed
182. 182.↵
     1. Oranger M,
     2. Gonzalez-Bermejo J,
     3. Dacosta-Noble P,
     4. Llontop C,
     5. Guerder A,
     6. Trosini-Desert V,
     7. et al

     . Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control study. Eur Respir J 2020;56(2):2001692.

     OpenUrlAbstract/FREE Full Text
183. 183.↵
     1. Brusasco C,
     2. Corradi F,
     3. Di Domenico A,
     4. Raggi F,
     5. Timossi G,
     6. Santori G,
     7. et al

     . Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure. Eur Respir J 2021;57(2):2002524.

     OpenUrlAbstract/FREE Full Text
184. 184.↵
     1. Sivaloganathan AA,
     2. Nasim-Mohi M,
     3. Brown MM,
     4. Abdul N,
     5. Jackson A,
     6. Fletcher SV,
     7. et al

     . Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre. Br J Anaesth 2020;125(4):e368-e371.

     OpenUrl
185. 185.↵
     1. Avdeev SN,
     2. Yaroshetskiy AI,
     3. Tsareva NA,
     4. Merzhoeva ZM,
     5. Trushenko NV,
     6. Nekludova GV,
     7. et al

     . Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19. Am J Emerg Med 2021;39:154-157.

     OpenUrlCrossRef
186. 186.↵
     1. Aliberti S,
     2. Radovanovic D,
     3. Billi F,
     4. Sotgiu G,
     5. Costanzo M,
     6. Pilocane T,
     7. et al

     . Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study. Eur Respir J 2020;56(4):2001935.

     OpenUrlAbstract/FREE Full Text
187. 187.↵
     1. Gaulton TG,
     2. Bellani G,
     3. Foti G,
     4. Frazer MJ,
     5. Fuchs BD,
     6. Cereda M

     . Early clinical experience in using helmet continuous positive airway pressure and high-flow nasal cannula in overweight and obese patients with acute hypoxemic respiratory failure from coronavirus disease 2019. Crit Care Explor 2020;2(9):e0216.

     OpenUrl
188. 188.↵
     1. Bellani G,
     2. Grasselli G,
     3. Cecconi M,
     4. Antolini L,
     5. Borelli M,
     6. De Giacomi F,
     7. et al

     . Noninvasive ventilatory support of COVID-19 patients outside the intensive care units (ward-COVID). Ann Am Thorac Soc 2021 [Epub ahead of print] doi: doi:10.1513/Annals ATS.202008-1080OC.

     OpenUrlCrossRef
189. 189.↵
     1. Coppadoro A,
     2. Benini A,
     3. Fruscio R,
     4. Verga L,
     5. Mazzola P,
     6. Bellelli G,
     7. et al

     . Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak. Crit Care 2021;25(1):80.

     OpenUrl
190. 190.↵
     1. Grieco DL,
     2. Menga LS,
     3. Cesarano M,
     4. Rosà T,
     5. Spadaro S,
     6. Bitondo MM,
     7. et al

     . Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory failure: the HENIVOT randomized clinical trial. JAMA 2021;325(17):1731-1743.

     OpenUrl
191. 191.
     1. Baqi S,
     2. Naz A,
     3. Sayeed MA,
     4. Khan S,
     5. Ismail H,
     6. Kumar V,
     7. et al

     . Clinical characteristics and outcome of patients with severe COVID-19 pneumonia at a public sector hospital in Karachi, Pakistan. Cureus 2021;13(2):e13107.
192. 192.↵
     1. Menzella F,
     2. Barbieri C,
     3. Fontana M,
     4. Scelfo C,
     5. Castagnetti C,
     6. Ghidoni G,
     7. et al

     . Effectiveness of noninvasive ventilation in COVID-19 related-acute respiratory distress syndrome. Clin Respir J 2021 [Epub ahead of print] doi: DOI:10.1111/crj.13361.

     OpenUrlCrossRef
193. 193.↵
     1. Franco C,
     2. Facciolongo N,
     3. Tonelli R,
     4. Dongilli R,
     5. Vianello A,
     6. Pisani L,
     7. et al

     . Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia. Eur Respir J 2020;56(5):2002130.

     OpenUrlPubMed
194. 194.↵
     1. Di Domenico S,
     2. Coen D,
     3. Bergamaschi M,
     4. Albertini V,
     5. Ghezzi L,
     6. Cazzaniga MM,
     7. et al

     . Clinical characteristics and respiratory support of 310 COVID-19 patients, diagnosed at the emergency room: a single-center retrospective study. Intern Emerg Med 2020 [Epub ahead of print].
195. 195.↵
     1. Kurtz P,
     2. Bastos LSL,
     3. Dantas LF,
     4. Zampieri FG,
     5. Soares M,
     6. Hamacher S,
     7. et al

     . Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months. Intensive Care Med 2021 [Epub ahead of print].
196. 196.↵
     1. Lee N,
     2. Hui D,
     3. Wu A,
     4. Chan P,
     5. Cameron P,
     6. Joynt GM,
     7. et al

     . A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348(20):1986-1994.

     OpenUrlCrossRefPubMedWeb of Science
197. 197.↵
     1. Booth CM,
     2. Matukas LM,
     3. Tomlinson GA,
     4. Rachlis AR,
     5. Rose DB,
     6. Dwosh HA,
     7. et al

     . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003;289(21):2801-2809.

     OpenUrlCrossRefPubMedWeb of Science
198. 198.↵
     1. Lew TWK,
     2. Kwek TK,
     3. Tai D,
     4. Earnest A,
     5. Loo S,
     6. Singh K,
     7. et al

     . Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 2003;290(3):374-380.

     OpenUrlCrossRefPubMedWeb of Science
199. 199.↵
     1. Murray JF,
     2. Matthay MA,
     3. Luce JM,
     4. Flick MR

     . An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988;138(3):720-723.

     OpenUrlCrossRefPubMedWeb of Science
200. 200.↵
     1. Bernard GR,
     2. Artigas A,
     3. Brigham KL,
     4. Carlet J,
     5. Falke K,
     6. Hudson L,
     7. et al

     . The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3 Pt 1):818-824.

     OpenUrlCrossRefPubMedWeb of Science